Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group
- PMID: 1998761
- PMCID: PMC1669057
- DOI: 10.1136/bmj.302.6770.210
Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group
Abstract
Objective: To compare the efficacy of angiotensin converting enzyme inhibition with calcium antagonism in diabetic patients with microalbuminuria.
Design: Randomised study of diabetic patients with microalbuminuria treated with perindopril or nifedipine for 12 months and monitored for one or three months after stopping treatment depending on whether they were hypertensive or normotensive. Patients were randomised separately according to whether they were hypertensive or normotensive.
Setting: Diabetic clinics in three university teaching hospitals.
Patients: 50 diabetic patients with persistent microalbuminuria. In all, 43 completed the study: 30 were normotensive and 13 hypertensive; 19 had type I diabetes and 24 had type II diabetes.
Interventions: For 12 months 20 patients were given perindopril 2-8 mg daily and 23 were given nifedipine 20-80 mg daily.
Main outcome measures: Albumin excretion rate, blood pressure, and glomerular filtration rate.
Results: Both perindopril and nifedipine significantly reduced mean blood pressure. During treatment there was no significant difference between those treated with perindopril and those treated with nifedipine with respect to albuminuria or mean blood pressure. Stopping treatment with both drugs was associated with a sustained increase in albuminuria and mean blood pressure. There was a significant correlation between mean blood pressure and albuminuria and also between the reduction in mean blood pressure and the decrease in albuminuria during treatment with both drugs. In hypertensive patients both drugs caused significant decreases in mean blood pressure and albuminuria. In normotensive patients there was no significant reduction in albuminuria with either regimen.
Conclusions: In diabetic patients with microalbuminuria blood pressure seems to be an important determinant of urinary albumin excretion. Perindopril and nifedipine have similar effects on urinary albumin excretion, both preventing increases in albuminuria in normotensive patients and decreasing albuminuria in hypertensive patients.
Comment in
-
Discontinuing ACE inhibition in patients with diabetic nephropathy.BMJ. 1991 Mar 16;302(6777):658. doi: 10.1136/bmj.302.6777.658. BMJ. 1991. PMID: 2012888 Free PMC article. Clinical Trial. No abstract available.
Similar articles
-
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.Diabet Med. 2004 Nov;21(11):1192-9. doi: 10.1111/j.1464-5491.2004.01316.x. Diabet Med. 2004. PMID: 15498085 Clinical Trial.
-
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.Am J Kidney Dis. 2001 May;37(5):890-9. doi: 10.1016/s0272-6386(05)80003-4. Am J Kidney Dis. 2001. PMID: 11325669 Clinical Trial.
-
Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.Diabete Metab. 1990 Jan-Feb;16(1):30-6. Diabete Metab. 1990. PMID: 2185055 Clinical Trial.
-
Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.J Hypertens Suppl. 1996 Dec;14(6):S11-4. J Hypertens Suppl. 1996. PMID: 9023709 Review.
-
Perindopril safety and tolerance in at-risk patients.Drugs. 1990;39 Suppl 1:64-70. doi: 10.2165/00003495-199000391-00010. Drugs. 1990. PMID: 2407494 Review.
Cited by
-
First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.J Hum Hypertens. 2018 Jul;32(7):494-506. doi: 10.1038/s41371-018-0066-x. Epub 2018 May 1. J Hum Hypertens. 2018. PMID: 29713053
-
Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.Drugs. 1992 Apr;43(4):464-489. doi: 10.2165/00003495-199243040-00004. Drugs. 1992. PMID: 28421556 Review.
-
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.Curr Hypertens Rep. 2002 Oct;4(5):387-93. doi: 10.1007/s11906-002-0069-3. Curr Hypertens Rep. 2002. PMID: 12217258 Review.
-
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.Clin Investig. 1994 Dec;72(12):961-6. doi: 10.1007/BF00577736. Clin Investig. 1994. PMID: 7711427 Clinical Trial.
-
Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.Drugs. 1992;44 Suppl 1:74-84. doi: 10.2165/00003495-199200441-00014. Drugs. 1992. PMID: 1283588 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical